Inhibition of Notch-1 pathway is involved in rottlerin-induced tumor suppressive function in nasopharyngeal carcinoma

Yingying Hou1, Shaoyan Feng2, Lixia Wang1

  • 1The Cyrus Tang Hematology Center and Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China.

Oncotarget
|October 6, 2017
PubMed

Insights

Rottlerin suppresses nasopharyngeal carcinoma growth by inhibiting Notch-1 expression. This natural compound offers a potential therapeutic strategy by targeting the Notch signaling pathway in cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Rottlerin exhibits anti-cancer properties, but its precise molecular mechanisms remain unclear.
  • The Notch signaling pathway is implicated in cancer development and progression.
  • Targeting Notch signaling may offer therapeutic benefits for human cancers.

Purpose of the Study:

  • To investigate if rottlerin suppresses Notch-1 expression in nasopharyngeal carcinoma (NPC) cells.
  • To determine the impact of rottlerin on NPC cell proliferation, migration, invasion, apoptosis, and cell cycle.
  • To elucidate the role of Notch-1 in rottlerin's anti-cancer effects in NPC.

Main Methods:

  • Cell Counting Kit (CTG) assay for cell viability.
  • Flow cytometry for apoptosis and cell cycle analysis.
  • Scratch healing and Transwell assays for cell migration and invasion.
  • Western blotting to assess protein expression, including Notch-1.

Main Results:

  • Rottlerin treatment inhibited NPC cell growth, migration, and invasion.
  • Rottlerin induced apoptosis and caused cell cycle arrest at the G1 phase.
  • Notch-1 expression was significantly reduced by rottlerin treatment.
  • Overexpression of Notch-1 promoted NPC cell growth and invasion, while its down-regulation inhibited these processes.
  • Restoring Notch-1 expression abrogated the anti-cancer effects of rottlerin.

Conclusions:

  • Rottlerin effectively inhibits nasopharyngeal carcinoma progression by down-regulating Notch-1.
  • Notch-1 plays a critical role in mediating the anti-cancer effects of rottlerin in NPC.
  • Notch-1 represents a promising therapeutic target for rottlerin-based nasopharyngeal carcinoma treatment.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
6.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K